|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.77 CNY | -0.20% |
|
+8.19% | -26.49% |
Shanghai Labway Clinical Laboratory Co., Ltd (SZSE:301060) announces a share repurchase program. Under the program, the company will repurchase up to CNY 30 million. The shares will be purchased at a price not exceeding CNY 21.09 per share.
The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months.
| 1st Jan change | Capi. | |
|---|---|---|
| -26.49% | 540M | |
| -17.89% | 8.25B | |
| +39.20% | 3.58B | |
| -39.11% | 2.46B | |
| -8.06% | 2.46B | |
| -7.35% | 2.38B | |
| -12.61% | 1.81B | |
| -19.01% | 1.55B | |
| -40.66% | 1.21B | |
| +7.56% | 1.11B |
SHANGHAI LABWAY CLINICAL LABORATORY CO., LTD 
